Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;110(3):773-780.
doi: 10.1111/apa.15557. Epub 2020 Sep 18.

How should we assess renal function in neonates and infants?

Affiliations
Review

How should we assess renal function in neonates and infants?

Guido Filler et al. Acta Paediatr. 2021 Mar.

Abstract

Aim: Review of current knowledge on assessing renal function in term and preterm neonates.

Methods: Literature review and analysis of own data.

Results: Prematurity, genetic, environmental and maternal factors may alter peak nephron endowment and life-long renal function. Nephrogenesis continues until 34-36 weeks of gestation, but it is altered with premature delivery. Variability of nephron endowment has a substantial impact on the clearance of renally excreted drugs. Postnatally, glomerular function rate (GFR) increases daily, doubles by two weeks, and slowly reaches full maturity at 18 months of age. Ideally, renal function biomarkers should be expressed as age-independent z-scores, and evidence suggests indexing these values to post-conceptual age rather than chronological age. Newborn and maternal serum creatinine correlate tightly for more than 72 hours after delivery, rendering this biomarker unsuitable for the assessment of neonatal renal function. Cystatin C does not cross the placenta and may be the preferred biomarker in the neonate. Here, we provide preliminary data on the natural evolution of the cystatin C eGFR in infancy.

Conclusion: Cystatin C may be superior for GFR estimation in neonates, but the best approach to drug dosing of renally excreted drugs remains to be established.

Keywords: creatinine; cystatin C; eGFR; nephron endowment; renal clearance.

PubMed Disclaimer

References

REFERENCES

    1. Filler G, Kirpalani A, Urquhart B. Handling of drugs in children with abnormal renal function. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein S, eds. Pediatric Nephrology. Berlin: Springer, Berlin Heidelberg, 2015.
    1. Filler G, Yasin A, Medeiros M. Methods of assessing renal function. Pediatr Nephrol. 2014;29(2):183-192.
    1. Filler G, Huang SH, Yasin A. The usefulness of cystatin C and related formulae in pediatrics. Clin Chem Lab Med. 2012;50(12):2081-2091.
    1. Filler G, Lopes L, Awuku M. The importance of accurately assessing renal function in the neonate and infant. Adv Clin Chem. 2015;71:141-156.
    1. Ceriotti F, Boyd JC, Klein G, et al. Reference intervals for serum creatinine concentrations: assessment of available data for global application. Clin Chem. 2008;54(3):559-566.

LinkOut - more resources